Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1471-2164-9-591.

Title:
Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate | BMC Genomics
Description:
Background Understanding the molecular control of cell lineages and fate determination in complex tissues is key to not only understanding the developmental biology and cellular homeostasis of such tissues but also for our understanding and interpretation of the molecular pathology of diseases such as cancer. The prerequisite for such an understanding is detailed knowledge of the cell types that make up such tissues, including their comprehensive molecular characterisation. In the mammary epithelium, the bulk of the tissue is composed of three cell lineages, namely the basal/myoepithelial, luminal epithelial estrogen receptor positive and luminal epithelial estrogen receptor negative cells. However, a detailed molecular characterisation of the transcriptomic differences between these three populations has not been carried out. Results A whole transcriptome analysis of basal/myoepithelial cells, luminal estrogen receptor negative cells and luminal estrogen receptor positive cells isolated from the virgin mouse mammary epithelium identified 861, 326 and 488 genes as highly differentially expressed in the three cell types, respectively. Network analysis of the transcriptomic data identified a subpopulation of luminal estrogen receptor negative cells with a novel potential role as non-professional immune cells. Analysis of the data for potential paracrine interacting factors showed that the basal/myoepithelial cells, remarkably, expressed over twice as many ligands and cell surface receptors as the other two populations combined. A number of transcriptional regulators were also identified that were differentially expressed between the cell lineages. One of these, Sox6, was specifically expressed in luminal estrogen receptor negative cells and functional assays confirmed that it maintained mammary epithelial cells in a differentiated luminal cell lineage. Conclusion The mouse mammary epithelium is composed of three main cell types with distinct gene expression patterns. These suggest the existence of a novel functional cell type within the gland, that the basal/myoepithelial cells are key regulators of paracrine signalling and that there is a complex network of differentially expressed transcription factors controlling mammary epithelial cell fate. These data will form the basis for understanding not only cell fate determination and cellular homeostasis in the normal mammary epithelium but also the contribution of different mammary epithelial cell types to the etiology and molecular pathology of breast disease.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Telecommunications

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We find it hard to spot revenue streams.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {πŸ”}

cells, luminal, cell, mammary, expression, pubmed, genes, gene, google, scholar, cas, epithelial, expressed, analysis, population, network, data, populations, additional, basalmyoepithelial, cancer, file, gland, mouse, sox, breast, interactions, differentially, nodes, factors, epithelium, figure, fate, receptor, signalling, krt, interaction, estrogen, identified, sca, qpcr, transcription, basal, central, gfp, modules, stem, transcriptional, fat, compared,

Topics {βœ’οΈ}

uk/collaborations/smalley/pops_gene_exp/miame/kendrick_miame_checklist sry-related high-mobility-group box open access article milk-secreting lobulo-alveolar structures cd24+/low sca-1- basal/myoepithelial guanine-nucleotide exchange factor acousto-optical beam splitter quantitative real-time rtpcr cdc2/cyclinb1 kinase inhibitors lymphoid-myeloid lineage diversification estrogen receptor-alpha knockout shaping t-cell activation cd24+/high sca-1+ cells cd24+/high sca-1- cells cell proliferation-related proteins anita grigoriadis transcription factors l-sox5 author information authors eph-ephrin bidirectional signaling luminal cell-fate commitment platelet-derived growth factor cd24+/low sca-1- cells fluorescence-activated cell sorting cd24+/high sca-1+ population double negative cells cell-type specific genes robust multi-array analysis basal/myoepithelial cell marker anti-cd24-pe-cy5 cd24+/high sca-1+ regions phycoerythrin-cy5 pe-cy7 key cell-intrinsic factors lineage-specific transcription factors article download pdf basal/myoepithelial cell dataset luminal epithelial fraction wild-type cells failed array-based expression pattern bmc cell biol cell stem cell estrogen responsive profile anti-sca-1 staining pattern anti-cd45-pe-cy5 basal/myoepithelial cell population g-protein coupled receptors basal/myoepithelial interaction map anti-cd45-pe-cy7 constitutive igf1/igf2 stimulation de-differentiation event resulting stem/progenitor fraction

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate
         description:Understanding the molecular control of cell lineages and fate determination in complex tissues is key to not only understanding the developmental biology and cellular homeostasis of such tissues but also for our understanding and interpretation of the molecular pathology of diseases such as cancer. The prerequisite for such an understanding is detailed knowledge of the cell types that make up such tissues, including their comprehensive molecular characterisation. In the mammary epithelium, the bulk of the tissue is composed of three cell lineages, namely the basal/myoepithelial, luminal epithelial estrogen receptor positive and luminal epithelial estrogen receptor negative cells. However, a detailed molecular characterisation of the transcriptomic differences between these three populations has not been carried out. A whole transcriptome analysis of basal/myoepithelial cells, luminal estrogen receptor negative cells and luminal estrogen receptor positive cells isolated from the virgin mouse mammary epithelium identified 861, 326 and 488 genes as highly differentially expressed in the three cell types, respectively. Network analysis of the transcriptomic data identified a subpopulation of luminal estrogen receptor negative cells with a novel potential role as non-professional immune cells. Analysis of the data for potential paracrine interacting factors showed that the basal/myoepithelial cells, remarkably, expressed over twice as many ligands and cell surface receptors as the other two populations combined. A number of transcriptional regulators were also identified that were differentially expressed between the cell lineages. One of these, Sox6, was specifically expressed in luminal estrogen receptor negative cells and functional assays confirmed that it maintained mammary epithelial cells in a differentiated luminal cell lineage. The mouse mammary epithelium is composed of three main cell types with distinct gene expression patterns. These suggest the existence of a novel functional cell type within the gland, that the basal/myoepithelial cells are key regulators of paracrine signalling and that there is a complex network of differentially expressed transcription factors controlling mammary epithelial cell fate. These data will form the basis for understanding not only cell fate determination and cellular homeostasis in the normal mammary epithelium but also the contribution of different mammary epithelial cell types to the etiology and molecular pathology of breast disease.
         datePublished:2008-12-08T00:00:00Z
         dateModified:2008-12-08T00:00:00Z
         pageStart:1
         pageEnd:28
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2164-9-591
         keywords:
            Mammary Epithelial Cell
            Mammary Epithelium
            Luminal Cell
            Luminal Epithelial Cell
            Double Negative Cell
            Life Sciences
            general
            Microarrays
            Proteomics
            Animal Genetics and Genomics
            Microbial Genetics and Genomics
            Plant Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig7_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig8_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig9_HTML.jpg
         isPartOf:
            name:BMC Genomics
            issn:
               1471-2164
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Howard Kendrick
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joseph L Regan
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fiona-Ann Magnay
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anita Grigoriadis
               affiliation:
                     name:Guy's Hospital
                     address:
                        name:Breakthrough Breast Cancer Research Unit, Guy's Hospital, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Costas Mitsopoulos
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marketa Zvelebil
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthew J Smalley
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate
      description:Understanding the molecular control of cell lineages and fate determination in complex tissues is key to not only understanding the developmental biology and cellular homeostasis of such tissues but also for our understanding and interpretation of the molecular pathology of diseases such as cancer. The prerequisite for such an understanding is detailed knowledge of the cell types that make up such tissues, including their comprehensive molecular characterisation. In the mammary epithelium, the bulk of the tissue is composed of three cell lineages, namely the basal/myoepithelial, luminal epithelial estrogen receptor positive and luminal epithelial estrogen receptor negative cells. However, a detailed molecular characterisation of the transcriptomic differences between these three populations has not been carried out. A whole transcriptome analysis of basal/myoepithelial cells, luminal estrogen receptor negative cells and luminal estrogen receptor positive cells isolated from the virgin mouse mammary epithelium identified 861, 326 and 488 genes as highly differentially expressed in the three cell types, respectively. Network analysis of the transcriptomic data identified a subpopulation of luminal estrogen receptor negative cells with a novel potential role as non-professional immune cells. Analysis of the data for potential paracrine interacting factors showed that the basal/myoepithelial cells, remarkably, expressed over twice as many ligands and cell surface receptors as the other two populations combined. A number of transcriptional regulators were also identified that were differentially expressed between the cell lineages. One of these, Sox6, was specifically expressed in luminal estrogen receptor negative cells and functional assays confirmed that it maintained mammary epithelial cells in a differentiated luminal cell lineage. The mouse mammary epithelium is composed of three main cell types with distinct gene expression patterns. These suggest the existence of a novel functional cell type within the gland, that the basal/myoepithelial cells are key regulators of paracrine signalling and that there is a complex network of differentially expressed transcription factors controlling mammary epithelial cell fate. These data will form the basis for understanding not only cell fate determination and cellular homeostasis in the normal mammary epithelium but also the contribution of different mammary epithelial cell types to the etiology and molecular pathology of breast disease.
      datePublished:2008-12-08T00:00:00Z
      dateModified:2008-12-08T00:00:00Z
      pageStart:1
      pageEnd:28
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2164-9-591
      keywords:
         Mammary Epithelial Cell
         Mammary Epithelium
         Luminal Cell
         Luminal Epithelial Cell
         Double Negative Cell
         Life Sciences
         general
         Microarrays
         Proteomics
         Animal Genetics and Genomics
         Microbial Genetics and Genomics
         Plant Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig7_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig8_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2164-9-591/MediaObjects/12864_2008_Article_1784_Fig9_HTML.jpg
      isPartOf:
         name:BMC Genomics
         issn:
            1471-2164
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Howard Kendrick
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joseph L Regan
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fiona-Ann Magnay
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anita Grigoriadis
            affiliation:
                  name:Guy's Hospital
                  address:
                     name:Breakthrough Breast Cancer Research Unit, Guy's Hospital, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Costas Mitsopoulos
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marketa Zvelebil
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthew J Smalley
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Genomics
      issn:
         1471-2164
      volumeNumber:9
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:Guy's Hospital
      address:
         name:Breakthrough Breast Cancer Research Unit, Guy's Hospital, London, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Howard Kendrick
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Joseph L Regan
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Fiona-Ann Magnay
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Anita Grigoriadis
      affiliation:
            name:Guy's Hospital
            address:
               name:Breakthrough Breast Cancer Research Unit, Guy's Hospital, London, UK
               type:PostalAddress
            type:Organization
      name:Costas Mitsopoulos
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Marketa Zvelebil
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Matthew J Smalley
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:Breakthrough Breast Cancer Research Unit, Guy's Hospital, London, UK
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK

External Links {πŸ”—}(313)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

6.3s.